Literature DB >> 19764348

Neural reflex hypotension induced by very small dose of hypertonic NaCl solution in rats.

Dongmei Zhang1, Takayuki Sato, Dezheng Gong, Lei Fu, Shufang Dai, Hong Xu, Qiong Wu, Dongmei Wang, Yan Peng, Yiping Sun.   

Abstract

Although the precise mechanisms of transient hypotension after intravenous infusion of hypertonic saline (HTS) are not yet clarified, a rapid infusion of HTS is widely used as the initial therapy of hypovolemia. We investigated the effect of the intravenous infusion of a small dose of 0.97-9.7% NaCl solutions in anesthetized rats. Intravenous infusion of HTS at a rate of 0.3 ml/kg/min for 1 min produced the transient hypotension lasting for several minutes. The depressor response to HTS was not abolished by bilateral cervical vagotomy. The HTS infusion into the femoral vein evoked the depressor response with a larger magnitude and a shorter latency than that into the aortic arch. While the arterial baroreceptor pressure was kept constant at the baseline level of systemic arterial pressure, HTS-induced hypotension was significantly augmented. The gain factor of the arterial baroreflex was reduced by intravenous HTS. Pretreatment with bretylium tosylate completely abolished the depressor response without affecting the baseline level of arterial pressure. These results suggest that the depressor response to the very small dose of intravenous HTS is the sympathosympathetic neural reflex with cardiopulmonary afferents and vasomotor efferents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764348     DOI: 10.4077/cjp.2009.amg079

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  2 in total

1.  Intravenous infusion of hyperosmotic NaCl solution induces acute cor pulmonale in anesthetized rats.

Authors:  Chikara Abe; Yoshiharu Tsuru; Chihiro Iwata; Ryosuke Ogihara; Hironobu Morita
Journal:  J Physiol Sci       Date:  2012-09-27       Impact factor: 2.781

2.  Treatment of elevated intracranial pressure with hyperosmolar therapy in patients with renal failure.

Authors:  Karen G Hirsch; Todd Spock; Matthew A Koenig; Romergryko G Geocadin
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.